Filament Health Corp. (NEO: FH.NE) Stock Competitors & Peer Comparison
See FH.NE's competitors and their performance on the NEO and across the wider stock market.
Peer Comparison Table: Drug Manufacturers - Specialty & Generic Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for FH.NE and its NEO peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| FH.NE | CA$0.01 | -33.33% | 3.9M | -0.50 | -CA$0.02 | N/A |
| APTX.TO | CA$33.02 | -2.51% | 7.6B | 20.58 | CA$1.61 | N/A |
| CURA.CN | CA$5.22 | +9.21% | 4.1B | -6.07 | -CA$0.86 | N/A |
| BHC.TO | CA$9.02 | +2.27% | 3.5B | 2.50 | CA$3.69 | N/A |
| CURA.TO | CA$13.40 | -2.40% | 3.1B | 49.46 | CA$0.27 | N/A |
| TRUL.CN | CA$16.14 | -11.07% | 2.7B | -29.01 | -CA$0.56 | N/A |
| GTII.CN | CA$10.42 | -1.23% | 2.4B | 13.97 | CA$0.75 | N/A |
| VRNO.CN | CA$6.32 | +6.76% | 2.2B | -5.40 | -CA$1.17 | N/A |
| CRON.TO | CA$4.84 | +5.57% | 1.8B | 118.59 | CA$0.04 | N/A |
| GUD.TO | CA$9.83 | +1.76% | 948.4M | 64.17 | CA$0.15 | N/A |
Stock Comparison
Apotex Health Corp. (TSX: APTX.TO)
FH.NE vs APTX.TO Comparison August 2026
Filament Health Corp. (NEO: FH.NE) plays a significant role within the Healthcare sector. Its performance on the NEO reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FH.NE stands at 3.9M. In comparison, APTX.TO has a market cap of 7.6B. Regarding current trading prices, FH.NE is priced at CA$0.01 on the NEO, while APTX.TO trades at CA$33.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FH.NE currently has a P/E ratio of -0.50, whereas APTX.TO's P/E ratio is 20.58. In terms of profitability, FH.NE's ROE is -1.38%, compared to APTX.TO's ROE of -2.80%. Regarding short-term risk, FH.NE is more volatile compared to APTX.TO. This indicates higher risk in terms of short-term price fluctuations for FH.NE.Check APTX.TO's competition here
Curaleaf Holdings, Inc. (CNQ: CURA.CN)
FH.NE vs CURA.CN Comparison August 2026
Filament Health Corp. (NEO: FH.NE) plays a significant role within the Healthcare sector. Its performance on the NEO reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FH.NE stands at 3.9M. In comparison, CURA.CN has a market cap of 4.1B. Regarding current trading prices, FH.NE is priced at CA$0.01 on the NEO, while CURA.CN trades at CA$5.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FH.NE currently has a P/E ratio of -0.50, whereas CURA.CN's P/E ratio is -6.07. In terms of profitability, FH.NE's ROE is -1.38%, compared to CURA.CN's ROE of -0.13%. Regarding short-term risk, FH.NE is more volatile compared to CURA.CN. This indicates higher risk in terms of short-term price fluctuations for FH.NE.Check CURA.CN's competition here
Bausch Health Companies Inc. (TSX: BHC.TO)
FH.NE vs BHC.TO Comparison August 2026
Filament Health Corp. (NEO: FH.NE) plays a significant role within the Healthcare sector. Its performance on the NEO reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FH.NE stands at 3.9M. In comparison, BHC.TO has a market cap of 3.5B. Regarding current trading prices, FH.NE is priced at CA$0.01 on the NEO, while BHC.TO trades at CA$9.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FH.NE currently has a P/E ratio of -0.50, whereas BHC.TO's P/E ratio is 2.50. In terms of profitability, FH.NE's ROE is -1.38%, compared to BHC.TO's ROE of +0.88%. Regarding short-term risk, FH.NE is more volatile compared to BHC.TO. This indicates higher risk in terms of short-term price fluctuations for FH.NE.Check BHC.TO's competition here
Curaleaf Holdings, Inc. (TSX: CURA.TO)
FH.NE vs CURA.TO Comparison August 2026
Filament Health Corp. (NEO: FH.NE) plays a significant role within the Healthcare sector. Its performance on the NEO reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FH.NE stands at 3.9M. In comparison, CURA.TO has a market cap of 3.1B. Regarding current trading prices, FH.NE is priced at CA$0.01 on the NEO, while CURA.TO trades at CA$13.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FH.NE currently has a P/E ratio of -0.50, whereas CURA.TO's P/E ratio is 49.46. In terms of profitability, FH.NE's ROE is -1.38%, compared to CURA.TO's ROE of -0.05%. Regarding short-term risk, FH.NE is more volatile compared to CURA.TO. This indicates higher risk in terms of short-term price fluctuations for FH.NE.Check CURA.TO's competition here
Trulieve Cannabis Corp. (CNQ: TRUL.CN)
FH.NE vs TRUL.CN Comparison August 2026
Filament Health Corp. (NEO: FH.NE) plays a significant role within the Healthcare sector. Its performance on the NEO reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FH.NE stands at 3.9M. In comparison, TRUL.CN has a market cap of 2.7B. Regarding current trading prices, FH.NE is priced at CA$0.01 on the NEO, while TRUL.CN trades at CA$16.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FH.NE currently has a P/E ratio of -0.50, whereas TRUL.CN's P/E ratio is -29.01. In terms of profitability, FH.NE's ROE is -1.38%, compared to TRUL.CN's ROE of -0.07%. Regarding short-term risk, FH.NE is more volatile compared to TRUL.CN. This indicates higher risk in terms of short-term price fluctuations for FH.NE.Check TRUL.CN's competition here
Green Thumb Industries Inc. (CNQ: GTII.CN)
FH.NE vs GTII.CN Comparison August 2026
Filament Health Corp. (NEO: FH.NE) plays a significant role within the Healthcare sector. Its performance on the NEO reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FH.NE stands at 3.9M. In comparison, GTII.CN has a market cap of 2.4B. Regarding current trading prices, FH.NE is priced at CA$0.01 on the NEO, while GTII.CN trades at CA$10.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FH.NE currently has a P/E ratio of -0.50, whereas GTII.CN's P/E ratio is 13.97. In terms of profitability, FH.NE's ROE is -1.38%, compared to GTII.CN's ROE of +0.07%. Regarding short-term risk, FH.NE is more volatile compared to GTII.CN. This indicates higher risk in terms of short-term price fluctuations for FH.NE.Check GTII.CN's competition here
Verano Holdings Corp. (CNQ: VRNO.CN)
FH.NE vs VRNO.CN Comparison August 2026
Filament Health Corp. (NEO: FH.NE) plays a significant role within the Healthcare sector. Its performance on the NEO reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FH.NE stands at 3.9M. In comparison, VRNO.CN has a market cap of 2.2B. Regarding current trading prices, FH.NE is priced at CA$0.01 on the NEO, while VRNO.CN trades at CA$6.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FH.NE currently has a P/E ratio of -0.50, whereas VRNO.CN's P/E ratio is -5.40. In terms of profitability, FH.NE's ROE is -1.38%, compared to VRNO.CN's ROE of -0.03%. Regarding short-term risk, FH.NE is more volatile compared to VRNO.CN. This indicates higher risk in terms of short-term price fluctuations for FH.NE.Check VRNO.CN's competition here
Cronos Group Inc. (TSX: CRON.TO)
FH.NE vs CRON.TO Comparison August 2026
Filament Health Corp. (NEO: FH.NE) plays a significant role within the Healthcare sector. Its performance on the NEO reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FH.NE stands at 3.9M. In comparison, CRON.TO has a market cap of 1.8B. Regarding current trading prices, FH.NE is priced at CA$0.01 on the NEO, while CRON.TO trades at CA$4.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FH.NE currently has a P/E ratio of -0.50, whereas CRON.TO's P/E ratio is 118.59. In terms of profitability, FH.NE's ROE is -1.38%, compared to CRON.TO's ROE of +0.06%. Regarding short-term risk, FH.NE is more volatile compared to CRON.TO. This indicates higher risk in terms of short-term price fluctuations for FH.NE.Check CRON.TO's competition here
Knight Therapeutics Inc. (TSX: GUD.TO)
FH.NE vs GUD.TO Comparison August 2026
Filament Health Corp. (NEO: FH.NE) plays a significant role within the Healthcare sector. Its performance on the NEO reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FH.NE stands at 3.9M. In comparison, GUD.TO has a market cap of 948.4M. Regarding current trading prices, FH.NE is priced at CA$0.01 on the NEO, while GUD.TO trades at CA$9.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FH.NE currently has a P/E ratio of -0.50, whereas GUD.TO's P/E ratio is 64.17. In terms of profitability, FH.NE's ROE is -1.38%, compared to GUD.TO's ROE of +0.02%. Regarding short-term risk, FH.NE is more volatile compared to GUD.TO. This indicates higher risk in terms of short-term price fluctuations for FH.NE.Check GUD.TO's competition here
TerrAscend Corp. (CNQ: TER.CN)
FH.NE vs TER.CN Comparison August 2026
Filament Health Corp. (NEO: FH.NE) plays a significant role within the Healthcare sector. Its performance on the NEO reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FH.NE stands at 3.9M. In comparison, TER.CN has a market cap of 804.8M. Regarding current trading prices, FH.NE is priced at CA$0.01 on the NEO, while TER.CN trades at CA$2.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FH.NE currently has a P/E ratio of -0.50, whereas TER.CN's P/E ratio is -1.33. In terms of profitability, FH.NE's ROE is -1.38%, compared to TER.CN's ROE of -0.44%. Regarding short-term risk, FH.NE is more volatile compared to TER.CN. This indicates higher risk in terms of short-term price fluctuations for FH.NE.Check TER.CN's competition here
Tilray Brands, Inc. (TSX: TLRY.TO)
FH.NE vs TLRY.TO Comparison August 2026
Filament Health Corp. (NEO: FH.NE) plays a significant role within the Healthcare sector. Its performance on the NEO reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FH.NE stands at 3.9M. In comparison, TLRY.TO has a market cap of 735.9M. Regarding current trading prices, FH.NE is priced at CA$0.01 on the NEO, while TLRY.TO trades at CA$6.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FH.NE currently has a P/E ratio of -0.50, whereas TLRY.TO's P/E ratio is -4.46. In terms of profitability, FH.NE's ROE is -1.38%, compared to TLRY.TO's ROE of -0.09%. Regarding short-term risk, FH.NE is more volatile compared to TLRY.TO. This indicates higher risk in terms of short-term price fluctuations for FH.NE.Check TLRY.TO's competition here
Verano Holdings Corp. (NEO: VRNO.NE)
FH.NE vs VRNO.NE Comparison August 2026
Filament Health Corp. (NEO: FH.NE) plays a significant role within the Healthcare sector. Its performance on the NEO reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FH.NE stands at 3.9M. In comparison, VRNO.NE has a market cap of 613.5M. Regarding current trading prices, FH.NE is priced at CA$0.01 on the NEO, while VRNO.NE trades at CA$8.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FH.NE currently has a P/E ratio of -0.50, whereas VRNO.NE's P/E ratio is -1.70. In terms of profitability, FH.NE's ROE is -1.38%, compared to VRNO.NE's ROE of -0.35%. Regarding short-term risk, FH.NE is more volatile compared to VRNO.NE. This indicates higher risk in terms of short-term price fluctuations for FH.NE.Check VRNO.NE's competition here
Columbia Care Inc. (NEO: CCHW.NE)
FH.NE vs CCHW.NE Comparison August 2026
Filament Health Corp. (NEO: FH.NE) plays a significant role within the Healthcare sector. Its performance on the NEO reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FH.NE stands at 3.9M. In comparison, CCHW.NE has a market cap of 407.2M. Regarding current trading prices, FH.NE is priced at CA$0.01 on the NEO, while CCHW.NE trades at CA$1.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FH.NE currently has a P/E ratio of -0.50, whereas CCHW.NE's P/E ratio is -3.52. In terms of profitability, FH.NE's ROE is -1.38%, compared to CCHW.NE's ROE of -1.07%. Regarding short-term risk, FH.NE is more volatile compared to CCHW.NE. This indicates higher risk in terms of short-term price fluctuations for FH.NE.Check CCHW.NE's competition here
Cresco Labs Inc. (CNQ: CL.CN)
FH.NE vs CL.CN Comparison August 2026
Filament Health Corp. (NEO: FH.NE) plays a significant role within the Healthcare sector. Its performance on the NEO reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FH.NE stands at 3.9M. In comparison, CL.CN has a market cap of 382.6M. Regarding current trading prices, FH.NE is priced at CA$0.01 on the NEO, while CL.CN trades at CA$1.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FH.NE currently has a P/E ratio of -0.50, whereas CL.CN's P/E ratio is -2.66. In terms of profitability, FH.NE's ROE is -1.38%, compared to CL.CN's ROE of -0.28%. Regarding short-term risk, FH.NE is more volatile compared to CL.CN. This indicates higher risk in terms of short-term price fluctuations for FH.NE.Check CL.CN's competition here
Cipher Pharmaceuticals Inc. (TSX: CPH.TO)
FH.NE vs CPH.TO Comparison August 2026
Filament Health Corp. (NEO: FH.NE) plays a significant role within the Healthcare sector. Its performance on the NEO reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FH.NE stands at 3.9M. In comparison, CPH.TO has a market cap of 358M. Regarding current trading prices, FH.NE is priced at CA$0.01 on the NEO, while CPH.TO trades at CA$14.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FH.NE currently has a P/E ratio of -0.50, whereas CPH.TO's P/E ratio is 9.17. In terms of profitability, FH.NE's ROE is -1.38%, compared to CPH.TO's ROE of +0.23%. Regarding short-term risk, FH.NE is more volatile compared to CPH.TO. This indicates higher risk in terms of short-term price fluctuations for FH.NE.Check CPH.TO's competition here
Aurora Cannabis Inc. (TSX: ACB.TO)
FH.NE vs ACB.TO Comparison August 2026
Filament Health Corp. (NEO: FH.NE) plays a significant role within the Healthcare sector. Its performance on the NEO reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FH.NE stands at 3.9M. In comparison, ACB.TO has a market cap of 338.8M. Regarding current trading prices, FH.NE is priced at CA$0.01 on the NEO, while ACB.TO trades at CA$5.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FH.NE currently has a P/E ratio of -0.50, whereas ACB.TO's P/E ratio is -2.82. In terms of profitability, FH.NE's ROE is -1.38%, compared to ACB.TO's ROE of -0.05%. Regarding short-term risk, FH.NE is more volatile compared to ACB.TO. This indicates higher risk in terms of short-term price fluctuations for FH.NE.Check ACB.TO's competition here
Auxly Cannabis Group Inc. (TSX: XLY.TO)
FH.NE vs XLY.TO Comparison August 2026
Filament Health Corp. (NEO: FH.NE) plays a significant role within the Healthcare sector. Its performance on the NEO reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FH.NE stands at 3.9M. In comparison, XLY.TO has a market cap of 316.1M. Regarding current trading prices, FH.NE is priced at CA$0.01 on the NEO, while XLY.TO trades at CA$3.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FH.NE currently has a P/E ratio of -0.50, whereas XLY.TO's P/E ratio is 9.40. In terms of profitability, FH.NE's ROE is -1.38%, compared to XLY.TO's ROE of +0.18%. Regarding short-term risk, FH.NE is more volatile compared to XLY.TO. This indicates higher risk in terms of short-term price fluctuations for FH.NE.Check XLY.TO's competition here
Cardiol Therapeutics Inc. (TSX: CRDL.TO)
FH.NE vs CRDL.TO Comparison August 2026
Filament Health Corp. (NEO: FH.NE) plays a significant role within the Healthcare sector. Its performance on the NEO reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FH.NE stands at 3.9M. In comparison, CRDL.TO has a market cap of 297.4M. Regarding current trading prices, FH.NE is priced at CA$0.01 on the NEO, while CRDL.TO trades at CA$2.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FH.NE currently has a P/E ratio of -0.50, whereas CRDL.TO's P/E ratio is -7.66. In terms of profitability, FH.NE's ROE is -1.38%, compared to CRDL.TO's ROE of -1.80%. Regarding short-term risk, FH.NE is more volatile compared to CRDL.TO. This indicates higher risk in terms of short-term price fluctuations for FH.NE.Check CRDL.TO's competition here
Canopy Growth Corporation (TSX: WEED.TO)
FH.NE vs WEED.TO Comparison August 2026
Filament Health Corp. (NEO: FH.NE) plays a significant role within the Healthcare sector. Its performance on the NEO reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FH.NE stands at 3.9M. In comparison, WEED.TO has a market cap of 265.3M. Regarding current trading prices, FH.NE is priced at CA$0.01 on the NEO, while WEED.TO trades at CA$1.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FH.NE currently has a P/E ratio of -0.50, whereas WEED.TO's P/E ratio is -2.36. In terms of profitability, FH.NE's ROE is -1.38%, compared to WEED.TO's ROE of -0.30%. Regarding short-term risk, FH.NE is more volatile compared to WEED.TO. This indicates higher risk in terms of short-term price fluctuations for FH.NE.Check WEED.TO's competition here
TerrAscend Corp. (TSX: TSND.TO)
FH.NE vs TSND.TO Comparison August 2026
Filament Health Corp. (NEO: FH.NE) plays a significant role within the Healthcare sector. Its performance on the NEO reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FH.NE stands at 3.9M. In comparison, TSND.TO has a market cap of 259.7M. Regarding current trading prices, FH.NE is priced at CA$0.01 on the NEO, while TSND.TO trades at CA$0.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FH.NE currently has a P/E ratio of -0.50, whereas TSND.TO's P/E ratio is -3.38. In terms of profitability, FH.NE's ROE is -1.38%, compared to TSND.TO's ROE of -0.46%. Regarding short-term risk, FH.NE is more volatile compared to TSND.TO. This indicates higher risk in terms of short-term price fluctuations for FH.NE.Check TSND.TO's competition here
Organigram Global Inc. (TSX: OGI.TO)
FH.NE vs OGI.TO Comparison August 2026
Filament Health Corp. (NEO: FH.NE) plays a significant role within the Healthcare sector. Its performance on the NEO reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FH.NE stands at 3.9M. In comparison, OGI.TO has a market cap of 236.1M. Regarding current trading prices, FH.NE is priced at CA$0.01 on the NEO, while OGI.TO trades at CA$1.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FH.NE currently has a P/E ratio of -0.50, whereas OGI.TO's P/E ratio is -8.92. In terms of profitability, FH.NE's ROE is -1.38%, compared to OGI.TO's ROE of +0.22%. Regarding short-term risk, FH.NE is more volatile compared to OGI.TO. This indicates higher risk in terms of short-term price fluctuations for FH.NE.Check OGI.TO's competition here
Columbia Care Inc. (CNQ: CCHW.CN)
FH.NE vs CCHW.CN Comparison August 2026
Filament Health Corp. (NEO: FH.NE) plays a significant role within the Healthcare sector. Its performance on the NEO reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FH.NE stands at 3.9M. In comparison, CCHW.CN has a market cap of 228.7M. Regarding current trading prices, FH.NE is priced at CA$0.01 on the NEO, while CCHW.CN trades at CA$0.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FH.NE currently has a P/E ratio of -0.50, whereas CCHW.CN's P/E ratio is -0.41. In terms of profitability, FH.NE's ROE is -1.38%, compared to CCHW.CN's ROE of -1.07%. Regarding short-term risk, FH.NE is more volatile compared to CCHW.CN. This indicates higher risk in terms of short-term price fluctuations for FH.NE.Check CCHW.CN's competition here
Theratechnologies Inc. (TSX: TH.TO)
FH.NE vs TH.TO Comparison August 2026
Filament Health Corp. (NEO: FH.NE) plays a significant role within the Healthcare sector. Its performance on the NEO reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FH.NE stands at 3.9M. In comparison, TH.TO has a market cap of 205.5M. Regarding current trading prices, FH.NE is priced at CA$0.01 on the NEO, while TH.TO trades at CA$4.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FH.NE currently has a P/E ratio of -0.50, whereas TH.TO's P/E ratio is -17.19. In terms of profitability, FH.NE's ROE is -1.38%, compared to TH.TO's ROE of +0.17%. Regarding short-term risk, FH.NE is more volatile compared to TH.TO. This indicates higher risk in terms of short-term price fluctuations for FH.NE.Check TH.TO's competition here
Cannara Biotech Inc. (TSX: LOVE.TO)
FH.NE vs LOVE.TO Comparison August 2026
Filament Health Corp. (NEO: FH.NE) plays a significant role within the Healthcare sector. Its performance on the NEO reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FH.NE stands at 3.9M. In comparison, LOVE.TO has a market cap of 197.6M. Regarding current trading prices, FH.NE is priced at CA$0.01 on the NEO, while LOVE.TO trades at CA$2.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FH.NE currently has a P/E ratio of -0.50, whereas LOVE.TO's P/E ratio is 17.32. In terms of profitability, FH.NE's ROE is -1.38%, compared to LOVE.TO's ROE of +0.09%. Regarding short-term risk, FH.NE is more volatile compared to LOVE.TO. This indicates higher risk in terms of short-term price fluctuations for FH.NE.Check LOVE.TO's competition here
Grown Rogue International Inc. (CNQ: GRIN.CN)
FH.NE vs GRIN.CN Comparison August 2026
Filament Health Corp. (NEO: FH.NE) plays a significant role within the Healthcare sector. Its performance on the NEO reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FH.NE stands at 3.9M. In comparison, GRIN.CN has a market cap of 165M. Regarding current trading prices, FH.NE is priced at CA$0.01 on the NEO, while GRIN.CN trades at CA$0.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FH.NE currently has a P/E ratio of -0.50, whereas GRIN.CN's P/E ratio is 40.07. In terms of profitability, FH.NE's ROE is -1.38%, compared to GRIN.CN's ROE of -0.13%. Regarding short-term risk, FH.NE is more volatile compared to GRIN.CN. This indicates higher risk in terms of short-term price fluctuations for FH.NE.Check GRIN.CN's competition here
BioHarvest Sciences Inc. (CNQ: BHSC.CN)
FH.NE vs BHSC.CN Comparison August 2026
Filament Health Corp. (NEO: FH.NE) plays a significant role within the Healthcare sector. Its performance on the NEO reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FH.NE stands at 3.9M. In comparison, BHSC.CN has a market cap of 137.8M. Regarding current trading prices, FH.NE is priced at CA$0.01 on the NEO, while BHSC.CN trades at CA$7.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FH.NE currently has a P/E ratio of -0.50, whereas BHSC.CN's P/E ratio is -4.37. In terms of profitability, FH.NE's ROE is -1.38%, compared to BHSC.CN's ROE of +1.91%. Regarding short-term risk, FH.NE is more volatile compared to BHSC.CN. This indicates higher risk in terms of short-term price fluctuations for FH.NE.Check BHSC.CN's competition here
Jushi Holdings Inc. (CNQ: JUSH.CN)
FH.NE vs JUSH.CN Comparison August 2026
Filament Health Corp. (NEO: FH.NE) plays a significant role within the Healthcare sector. Its performance on the NEO reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FH.NE stands at 3.9M. In comparison, JUSH.CN has a market cap of 129.8M. Regarding current trading prices, FH.NE is priced at CA$0.01 on the NEO, while JUSH.CN trades at CA$0.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FH.NE currently has a P/E ratio of -0.50, whereas JUSH.CN's P/E ratio is -1.35. In terms of profitability, FH.NE's ROE is -1.38%, compared to JUSH.CN's ROE of +0.53%. Regarding short-term risk, FH.NE is more volatile compared to JUSH.CN. This indicates higher risk in terms of short-term price fluctuations for FH.NE.Check JUSH.CN's competition here
HLS Therapeutics Inc. (TSX: HLS.TO)
FH.NE vs HLS.TO Comparison August 2026
Filament Health Corp. (NEO: FH.NE) plays a significant role within the Healthcare sector. Its performance on the NEO reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FH.NE stands at 3.9M. In comparison, HLS.TO has a market cap of 115.4M. Regarding current trading prices, FH.NE is priced at CA$0.01 on the NEO, while HLS.TO trades at CA$3.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FH.NE currently has a P/E ratio of -0.50, whereas HLS.TO's P/E ratio is -10.22. In terms of profitability, FH.NE's ROE is -1.38%, compared to HLS.TO's ROE of -0.14%. Regarding short-term risk, FH.NE is more volatile compared to HLS.TO. This indicates higher risk in terms of short-term price fluctuations for FH.NE.Check HLS.TO's competition here
Goodness Growth Holdings, Inc. (CNQ: GDNS.CN)
FH.NE vs GDNS.CN Comparison August 2026
Filament Health Corp. (NEO: FH.NE) plays a significant role within the Healthcare sector. Its performance on the NEO reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FH.NE stands at 3.9M. In comparison, GDNS.CN has a market cap of 91M. Regarding current trading prices, FH.NE is priced at CA$0.01 on the NEO, while GDNS.CN trades at CA$0.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FH.NE currently has a P/E ratio of -0.50, whereas GDNS.CN's P/E ratio is -2.74. In terms of profitability, FH.NE's ROE is -1.38%, compared to GDNS.CN's ROE of -0.13%. Regarding short-term risk, FH.NE is more volatile compared to GDNS.CN. This indicates higher risk in terms of short-term price fluctuations for FH.NE.Check GDNS.CN's competition here
Charlotte's Web Holdings, Inc. (TSX: CWEB.TO)
FH.NE vs CWEB.TO Comparison August 2026
Filament Health Corp. (NEO: FH.NE) plays a significant role within the Healthcare sector. Its performance on the NEO reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FH.NE stands at 3.9M. In comparison, CWEB.TO has a market cap of 73.4M. Regarding current trading prices, FH.NE is priced at CA$0.01 on the NEO, while CWEB.TO trades at CA$0.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FH.NE currently has a P/E ratio of -0.50, whereas CWEB.TO's P/E ratio is -1.58. In terms of profitability, FH.NE's ROE is -1.38%, compared to CWEB.TO's ROE of -2.84%. Regarding short-term risk, FH.NE is more volatile compared to CWEB.TO. This indicates higher risk in terms of short-term price fluctuations for FH.NE.Check CWEB.TO's competition here
Vext Science, Inc. (CNQ: VEXT.CN)
FH.NE vs VEXT.CN Comparison August 2026
Filament Health Corp. (NEO: FH.NE) plays a significant role within the Healthcare sector. Its performance on the NEO reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FH.NE stands at 3.9M. In comparison, VEXT.CN has a market cap of 71.8M. Regarding current trading prices, FH.NE is priced at CA$0.01 on the NEO, while VEXT.CN trades at CA$0.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FH.NE currently has a P/E ratio of -0.50, whereas VEXT.CN's P/E ratio is -2.87. In terms of profitability, FH.NE's ROE is -1.38%, compared to VEXT.CN's ROE of -0.25%. Regarding short-term risk, FH.NE is more volatile compared to VEXT.CN. This indicates higher risk in terms of short-term price fluctuations for FH.NE.Check VEXT.CN's competition here
Planet 13 Holdings Inc. (CNQ: PLTH.CN)
FH.NE vs PLTH.CN Comparison August 2026
Filament Health Corp. (NEO: FH.NE) plays a significant role within the Healthcare sector. Its performance on the NEO reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FH.NE stands at 3.9M. In comparison, PLTH.CN has a market cap of 62.4M. Regarding current trading prices, FH.NE is priced at CA$0.01 on the NEO, while PLTH.CN trades at CA$0.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FH.NE currently has a P/E ratio of -0.50, whereas PLTH.CN's P/E ratio is -0.75. In terms of profitability, FH.NE's ROE is -1.38%, compared to PLTH.CN's ROE of -1.32%. Regarding short-term risk, FH.NE is more volatile compared to PLTH.CN. This indicates higher risk in terms of short-term price fluctuations for FH.NE.Check PLTH.CN's competition here
The Green Organic Dutchman Holdings Ltd. (CNQ: TGOD.CN)
FH.NE vs TGOD.CN Comparison August 2026
Filament Health Corp. (NEO: FH.NE) plays a significant role within the Healthcare sector. Its performance on the NEO reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FH.NE stands at 3.9M. In comparison, TGOD.CN has a market cap of 62.2M. Regarding current trading prices, FH.NE is priced at CA$0.01 on the NEO, while TGOD.CN trades at CA$0.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FH.NE currently has a P/E ratio of -0.50, whereas TGOD.CN's P/E ratio is -3.28. In terms of profitability, FH.NE's ROE is -1.38%, compared to TGOD.CN's ROE of +0.01%. Regarding short-term risk, FH.NE is more volatile compared to TGOD.CN. This indicates higher risk in terms of short-term price fluctuations for FH.NE.Check TGOD.CN's competition here
Leef Brands Inc. (CNQ: LEEF.CN)
FH.NE vs LEEF.CN Comparison August 2026
Filament Health Corp. (NEO: FH.NE) plays a significant role within the Healthcare sector. Its performance on the NEO reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FH.NE stands at 3.9M. In comparison, LEEF.CN has a market cap of 58.6M. Regarding current trading prices, FH.NE is priced at CA$0.01 on the NEO, while LEEF.CN trades at CA$0.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FH.NE currently has a P/E ratio of -0.50, whereas LEEF.CN's P/E ratio is -29.69. In terms of profitability, FH.NE's ROE is -1.38%, compared to LEEF.CN's ROE of +2.07%. Regarding short-term risk, FH.NE is more volatile compared to LEEF.CN. This indicates higher risk in terms of short-term price fluctuations for FH.NE.Check LEEF.CN's competition here
Stem Holdings, Inc. (CNQ: STEM.CN)
FH.NE vs STEM.CN Comparison August 2026
Filament Health Corp. (NEO: FH.NE) plays a significant role within the Healthcare sector. Its performance on the NEO reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FH.NE stands at 3.9M. In comparison, STEM.CN has a market cap of 53.6M. Regarding current trading prices, FH.NE is priced at CA$0.01 on the NEO, while STEM.CN trades at CA$0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FH.NE currently has a P/E ratio of -0.50, whereas STEM.CN's P/E ratio is -0.00. In terms of profitability, FH.NE's ROE is -1.38%, compared to STEM.CN's ROE of -2.75%. Regarding short-term risk, FH.NE is more volatile compared to STEM.CN. This indicates higher risk in terms of short-term price fluctuations for FH.NE.Check STEM.CN's competition here
C21 Investments Inc. (CNQ: CXXI.CN)
FH.NE vs CXXI.CN Comparison August 2026
Filament Health Corp. (NEO: FH.NE) plays a significant role within the Healthcare sector. Its performance on the NEO reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FH.NE stands at 3.9M. In comparison, CXXI.CN has a market cap of 45.7M. Regarding current trading prices, FH.NE is priced at CA$0.01 on the NEO, while CXXI.CN trades at CA$0.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FH.NE currently has a P/E ratio of -0.50, whereas CXXI.CN's P/E ratio is -12.74. In terms of profitability, FH.NE's ROE is -1.38%, compared to CXXI.CN's ROE of -0.17%. Regarding short-term risk, FH.NE is more volatile compared to CXXI.CN. This indicates higher risk in terms of short-term price fluctuations for FH.NE.Check CXXI.CN's competition here
MariMed Inc. (CNQ: MRMD.CN)
FH.NE vs MRMD.CN Comparison August 2026
Filament Health Corp. (NEO: FH.NE) plays a significant role within the Healthcare sector. Its performance on the NEO reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FH.NE stands at 3.9M. In comparison, MRMD.CN has a market cap of 43.9M. Regarding current trading prices, FH.NE is priced at CA$0.01 on the NEO, while MRMD.CN trades at CA$0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FH.NE currently has a P/E ratio of -0.50, whereas MRMD.CN's P/E ratio is -3.91. In terms of profitability, FH.NE's ROE is -1.38%, compared to MRMD.CN's ROE of -0.30%. Regarding short-term risk, FH.NE is more volatile compared to MRMD.CN. This indicates higher risk in terms of short-term price fluctuations for FH.NE.Check MRMD.CN's competition here
BioNxt Solutions Inc. (CNQ: BNXT.CN)
FH.NE vs BNXT.CN Comparison August 2026
Filament Health Corp. (NEO: FH.NE) plays a significant role within the Healthcare sector. Its performance on the NEO reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FH.NE stands at 3.9M. In comparison, BNXT.CN has a market cap of 43.5M. Regarding current trading prices, FH.NE is priced at CA$0.01 on the NEO, while BNXT.CN trades at CA$0.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FH.NE currently has a P/E ratio of -0.50, whereas BNXT.CN's P/E ratio is -6.10. In terms of profitability, FH.NE's ROE is -1.38%, compared to BNXT.CN's ROE of +1.11%. Regarding short-term risk, FH.NE is more volatile compared to BNXT.CN. This indicates higher risk in terms of short-term price fluctuations for FH.NE.Check BNXT.CN's competition here
HEXO Corp. (TSX: HEXO.TO)
FH.NE vs HEXO.TO Comparison August 2026
Filament Health Corp. (NEO: FH.NE) plays a significant role within the Healthcare sector. Its performance on the NEO reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FH.NE stands at 3.9M. In comparison, HEXO.TO has a market cap of 38.7M. Regarding current trading prices, FH.NE is priced at CA$0.01 on the NEO, while HEXO.TO trades at CA$0.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FH.NE currently has a P/E ratio of -0.50, whereas HEXO.TO's P/E ratio is -0.26. In terms of profitability, FH.NE's ROE is -1.38%, compared to HEXO.TO's ROE of -2.06%. Regarding short-term risk, FH.NE is more volatile compared to HEXO.TO. This indicates higher risk in terms of short-term price fluctuations for FH.NE.Check HEXO.TO's competition here
Waverunner Capital Inc. (CNQ: CHM.CN)
FH.NE vs CHM.CN Comparison August 2026
Filament Health Corp. (NEO: FH.NE) plays a significant role within the Healthcare sector. Its performance on the NEO reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FH.NE stands at 3.9M. In comparison, CHM.CN has a market cap of 37.2M. Regarding current trading prices, FH.NE is priced at CA$0.01 on the NEO, while CHM.CN trades at CA$0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FH.NE currently has a P/E ratio of -0.50, whereas CHM.CN's P/E ratio is -5.00. In terms of profitability, FH.NE's ROE is -1.38%, compared to CHM.CN's ROE of +1.16%. Regarding short-term risk, FH.NE is more volatile compared to CHM.CN. This indicates higher risk in terms of short-term price fluctuations for FH.NE.Check CHM.CN's competition here
iAnthus Capital Holdings, Inc. (CNQ: IAN.CN)
FH.NE vs IAN.CN Comparison August 2026
Filament Health Corp. (NEO: FH.NE) plays a significant role within the Healthcare sector. Its performance on the NEO reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FH.NE stands at 3.9M. In comparison, IAN.CN has a market cap of 34.9M. Regarding current trading prices, FH.NE is priced at CA$0.01 on the NEO, while IAN.CN trades at CA$0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FH.NE currently has a P/E ratio of -0.50, whereas IAN.CN's P/E ratio is 7.94. In terms of profitability, FH.NE's ROE is -1.38%, compared to IAN.CN's ROE of +0.50%. Regarding short-term risk, FH.NE is more volatile compared to IAN.CN. This indicates higher risk in terms of short-term price fluctuations for FH.NE.Check IAN.CN's competition here
MediPharm Labs Corp. (TSX: LABS.TO)
FH.NE vs LABS.TO Comparison August 2026
Filament Health Corp. (NEO: FH.NE) plays a significant role within the Healthcare sector. Its performance on the NEO reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FH.NE stands at 3.9M. In comparison, LABS.TO has a market cap of 31.9M. Regarding current trading prices, FH.NE is priced at CA$0.01 on the NEO, while LABS.TO trades at CA$0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FH.NE currently has a P/E ratio of -0.50, whereas LABS.TO's P/E ratio is -3.47. In terms of profitability, FH.NE's ROE is -1.38%, compared to LABS.TO's ROE of -0.14%. Regarding short-term risk, FH.NE is more volatile compared to LABS.TO. This indicates higher risk in terms of short-term price fluctuations for FH.NE.Check LABS.TO's competition here
1CM Inc. (CNQ: EPIC.CN)
FH.NE vs EPIC.CN Comparison August 2026
Filament Health Corp. (NEO: FH.NE) plays a significant role within the Healthcare sector. Its performance on the NEO reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FH.NE stands at 3.9M. In comparison, EPIC.CN has a market cap of 30.6M. Regarding current trading prices, FH.NE is priced at CA$0.01 on the NEO, while EPIC.CN trades at CA$0.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FH.NE currently has a P/E ratio of -0.50, whereas EPIC.CN's P/E ratio is 7.08. In terms of profitability, FH.NE's ROE is -1.38%, compared to EPIC.CN's ROE of +0.15%. Regarding short-term risk, FH.NE is more volatile compared to EPIC.CN. This indicates higher risk in terms of short-term price fluctuations for FH.NE.Check EPIC.CN's competition here
MedMen Enterprises Inc. (CNQ: MMEN.CN)
FH.NE vs MMEN.CN Comparison August 2026
Filament Health Corp. (NEO: FH.NE) plays a significant role within the Healthcare sector. Its performance on the NEO reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FH.NE stands at 3.9M. In comparison, MMEN.CN has a market cap of 27.7M. Regarding current trading prices, FH.NE is priced at CA$0.01 on the NEO, while MMEN.CN trades at CA$0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FH.NE currently has a P/E ratio of -0.50, whereas MMEN.CN's P/E ratio is -0.13. In terms of profitability, FH.NE's ROE is -1.38%, compared to MMEN.CN's ROE of -0.96%. Regarding short-term risk, FH.NE is more volatile compared to MMEN.CN. This indicates higher risk in terms of short-term price fluctuations for FH.NE.Check MMEN.CN's competition here
Mountain Valley MD Holdings Inc. (CNQ: MVMD.CN)
FH.NE vs MVMD.CN Comparison August 2026
Filament Health Corp. (NEO: FH.NE) plays a significant role within the Healthcare sector. Its performance on the NEO reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FH.NE stands at 3.9M. In comparison, MVMD.CN has a market cap of 24.7M. Regarding current trading prices, FH.NE is priced at CA$0.01 on the NEO, while MVMD.CN trades at CA$0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FH.NE currently has a P/E ratio of -0.50, whereas MVMD.CN's P/E ratio is -4.27. In terms of profitability, FH.NE's ROE is -1.38%, compared to MVMD.CN's ROE of -3.14%. Regarding short-term risk, FH.NE is more volatile compared to MVMD.CN. This indicates higher risk in terms of short-term price fluctuations for FH.NE.Check MVMD.CN's competition here
YourWay Cannabis Brands Inc. (CNQ: YOUR.CN)
FH.NE vs YOUR.CN Comparison August 2026
Filament Health Corp. (NEO: FH.NE) plays a significant role within the Healthcare sector. Its performance on the NEO reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FH.NE stands at 3.9M. In comparison, YOUR.CN has a market cap of 22.9M. Regarding current trading prices, FH.NE is priced at CA$0.01 on the NEO, while YOUR.CN trades at CA$0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FH.NE currently has a P/E ratio of -0.50, whereas YOUR.CN's P/E ratio is 8.50. In terms of profitability, FH.NE's ROE is -1.38%, compared to YOUR.CN's ROE of -1.18%. Regarding short-term risk, FH.NE is more volatile compared to YOUR.CN. This indicates higher risk in terms of short-term price fluctuations for FH.NE.Check YOUR.CN's competition here
Optimi Health Corp. (CNQ: OPTI.CN)
FH.NE vs OPTI.CN Comparison August 2026
Filament Health Corp. (NEO: FH.NE) plays a significant role within the Healthcare sector. Its performance on the NEO reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FH.NE stands at 3.9M. In comparison, OPTI.CN has a market cap of 21.7M. Regarding current trading prices, FH.NE is priced at CA$0.01 on the NEO, while OPTI.CN trades at CA$6.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FH.NE currently has a P/E ratio of -0.50, whereas OPTI.CN's P/E ratio is -17.30. In terms of profitability, FH.NE's ROE is -1.38%, compared to OPTI.CN's ROE of -0.84%. Regarding short-term risk, FH.NE is more volatile compared to OPTI.CN. This indicates higher risk in terms of short-term price fluctuations for FH.NE.Check OPTI.CN's competition here
Mydecine Innovations Group Inc. (NEO: MYCO.NE)
FH.NE vs MYCO.NE Comparison August 2026
Filament Health Corp. (NEO: FH.NE) plays a significant role within the Healthcare sector. Its performance on the NEO reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FH.NE stands at 3.9M. In comparison, MYCO.NE has a market cap of 21.4M. Regarding current trading prices, FH.NE is priced at CA$0.01 on the NEO, while MYCO.NE trades at CA$0.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FH.NE currently has a P/E ratio of -0.50, whereas MYCO.NE's P/E ratio is -0.54. In terms of profitability, FH.NE's ROE is -1.38%, compared to MYCO.NE's ROE of +0.02%. Regarding short-term risk, FH.NE is more volatile compared to MYCO.NE. This indicates higher risk in terms of short-term price fluctuations for FH.NE.Check MYCO.NE's competition here
Vinergy Capital Inc. (CNQ: VIN.CN)
FH.NE vs VIN.CN Comparison August 2026
Filament Health Corp. (NEO: FH.NE) plays a significant role within the Healthcare sector. Its performance on the NEO reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FH.NE stands at 3.9M. In comparison, VIN.CN has a market cap of 20.2M. Regarding current trading prices, FH.NE is priced at CA$0.01 on the NEO, while VIN.CN trades at CA$0.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FH.NE currently has a P/E ratio of -0.50, whereas VIN.CN's P/E ratio is -0.67. In terms of profitability, FH.NE's ROE is -1.38%, compared to VIN.CN's ROE of -0.79%. Regarding short-term risk, FH.NE is not fully comparable compared to VIN.CN. This indicates unavailable risk data in terms of short-term price fluctuations for FH.NE.Check VIN.CN's competition here
Captiva Verde Wellness Corp. (CNQ: PWR.CN)
FH.NE vs PWR.CN Comparison August 2026
Filament Health Corp. (NEO: FH.NE) plays a significant role within the Healthcare sector. Its performance on the NEO reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FH.NE stands at 3.9M. In comparison, PWR.CN has a market cap of 18.3M. Regarding current trading prices, FH.NE is priced at CA$0.01 on the NEO, while PWR.CN trades at CA$0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FH.NE currently has a P/E ratio of -0.50, whereas PWR.CN's P/E ratio is -15.79. In terms of profitability, FH.NE's ROE is -1.38%, compared to PWR.CN's ROE of -0.83%. Regarding short-term risk, FH.NE is more volatile compared to PWR.CN. This indicates higher risk in terms of short-term price fluctuations for FH.NE.Check PWR.CN's competition here
Ayr Wellness Inc. (CNQ: AYR-A.CN)
FH.NE vs AYR-A.CN Comparison August 2026
Filament Health Corp. (NEO: FH.NE) plays a significant role within the Healthcare sector. Its performance on the NEO reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FH.NE stands at 3.9M. In comparison, AYR-A.CN has a market cap of 18.1M. Regarding current trading prices, FH.NE is priced at CA$0.01 on the NEO, while AYR-A.CN trades at CA$0.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FH.NE currently has a P/E ratio of -0.50, whereas AYR-A.CN's P/E ratio is -0.11. In terms of profitability, FH.NE's ROE is -1.38%, compared to AYR-A.CN's ROE of -0.75%. Regarding short-term risk, FH.NE is more volatile compared to AYR-A.CN. This indicates higher risk in terms of short-term price fluctuations for FH.NE.Check AYR-A.CN's competition here
Avicanna Inc. (TSX: AVCN.TO)
FH.NE vs AVCN.TO Comparison August 2026
Filament Health Corp. (NEO: FH.NE) plays a significant role within the Healthcare sector. Its performance on the NEO reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FH.NE stands at 3.9M. In comparison, AVCN.TO has a market cap of 17.6M. Regarding current trading prices, FH.NE is priced at CA$0.01 on the NEO, while AVCN.TO trades at CA$0.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FH.NE currently has a P/E ratio of -0.50, whereas AVCN.TO's P/E ratio is -6.33. In terms of profitability, FH.NE's ROE is -1.38%, compared to AVCN.TO's ROE of -1.08%. Regarding short-term risk, FH.NE is more volatile compared to AVCN.TO. This indicates higher risk in terms of short-term price fluctuations for FH.NE.Check AVCN.TO's competition here
IM Cannabis Corp. (CNQ: IMCC.CN)
FH.NE vs IMCC.CN Comparison August 2026
Filament Health Corp. (NEO: FH.NE) plays a significant role within the Healthcare sector. Its performance on the NEO reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FH.NE stands at 3.9M. In comparison, IMCC.CN has a market cap of 17.2M. Regarding current trading prices, FH.NE is priced at CA$0.01 on the NEO, while IMCC.CN trades at CA$5.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FH.NE currently has a P/E ratio of -0.50, whereas IMCC.CN's P/E ratio is -2.68. In terms of profitability, FH.NE's ROE is -1.38%, compared to IMCC.CN's ROE of -0.03%. Regarding short-term risk, FH.NE is more volatile compared to IMCC.CN. This indicates higher risk in terms of short-term price fluctuations for FH.NE.Check IMCC.CN's competition here
EXMceuticals Inc. (CNQ: EXM.CN)
FH.NE vs EXM.CN Comparison August 2026
Filament Health Corp. (NEO: FH.NE) plays a significant role within the Healthcare sector. Its performance on the NEO reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FH.NE stands at 3.9M. In comparison, EXM.CN has a market cap of 15.1M. Regarding current trading prices, FH.NE is priced at CA$0.01 on the NEO, while EXM.CN trades at CA$0.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FH.NE currently has a P/E ratio of -0.50, whereas EXM.CN's P/E ratio is -0.91. In terms of profitability, FH.NE's ROE is -1.38%, compared to EXM.CN's ROE of -18.63%. Regarding short-term risk, FH.NE is more volatile compared to EXM.CN. This indicates higher risk in terms of short-term price fluctuations for FH.NE.Check EXM.CN's competition here
Crescita Therapeutics Inc. (TSX: CTX.TO)
FH.NE vs CTX.TO Comparison August 2026
Filament Health Corp. (NEO: FH.NE) plays a significant role within the Healthcare sector. Its performance on the NEO reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FH.NE stands at 3.9M. In comparison, CTX.TO has a market cap of 14.7M. Regarding current trading prices, FH.NE is priced at CA$0.01 on the NEO, while CTX.TO trades at CA$0.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FH.NE currently has a P/E ratio of -0.50, whereas CTX.TO's P/E ratio is -42.52. In terms of profitability, FH.NE's ROE is -1.38%, compared to CTX.TO's ROE of -0.02%. Regarding short-term risk, FH.NE is more volatile compared to CTX.TO. This indicates higher risk in terms of short-term price fluctuations for FH.NE.Check CTX.TO's competition here
Chalice Brands Ltd. (CNQ: CHAL.CN)
FH.NE vs CHAL.CN Comparison August 2026
Filament Health Corp. (NEO: FH.NE) plays a significant role within the Healthcare sector. Its performance on the NEO reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FH.NE stands at 3.9M. In comparison, CHAL.CN has a market cap of 14.7M. Regarding current trading prices, FH.NE is priced at CA$0.01 on the NEO, while CHAL.CN trades at CA$0.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FH.NE currently has a P/E ratio of -0.50, whereas CHAL.CN's P/E ratio is -2.25. In terms of profitability, FH.NE's ROE is -1.38%, compared to CHAL.CN's ROE of +0.00%. Regarding short-term risk, FH.NE is more volatile compared to CHAL.CN. This indicates higher risk in terms of short-term price fluctuations for FH.NE.Check CHAL.CN's competition here
Red White & Bloom Brands Inc. (CNQ: RWB.CN)
FH.NE vs RWB.CN Comparison August 2026
Filament Health Corp. (NEO: FH.NE) plays a significant role within the Healthcare sector. Its performance on the NEO reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FH.NE stands at 3.9M. In comparison, RWB.CN has a market cap of 14.1M. Regarding current trading prices, FH.NE is priced at CA$0.01 on the NEO, while RWB.CN trades at CA$0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FH.NE currently has a P/E ratio of -0.50, whereas RWB.CN's P/E ratio is -0.16. In terms of profitability, FH.NE's ROE is -1.38%, compared to RWB.CN's ROE of +0.43%. Regarding short-term risk, FH.NE is more volatile compared to RWB.CN. This indicates higher risk in terms of short-term price fluctuations for FH.NE.Check RWB.CN's competition here
RIV Capital Inc. (CNQ: RIV.CN)
FH.NE vs RIV.CN Comparison August 2026
Filament Health Corp. (NEO: FH.NE) plays a significant role within the Healthcare sector. Its performance on the NEO reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FH.NE stands at 3.9M. In comparison, RIV.CN has a market cap of 13.7M. Regarding current trading prices, FH.NE is priced at CA$0.01 on the NEO, while RIV.CN trades at CA$0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FH.NE currently has a P/E ratio of -0.50, whereas RIV.CN's P/E ratio is -0.21. In terms of profitability, FH.NE's ROE is -1.38%, compared to RIV.CN's ROE of -1.13%. Regarding short-term risk, FH.NE is more volatile compared to RIV.CN. This indicates higher risk in terms of short-term price fluctuations for FH.NE.Check RIV.CN's competition here
Greenway Greenhouse Cannabis Corporation (CNQ: GWAY.CN)
FH.NE vs GWAY.CN Comparison August 2026
Filament Health Corp. (NEO: FH.NE) plays a significant role within the Healthcare sector. Its performance on the NEO reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FH.NE stands at 3.9M. In comparison, GWAY.CN has a market cap of 13.3M. Regarding current trading prices, FH.NE is priced at CA$0.01 on the NEO, while GWAY.CN trades at CA$0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FH.NE currently has a P/E ratio of -0.50, whereas GWAY.CN's P/E ratio is -15.38. In terms of profitability, FH.NE's ROE is -1.38%, compared to GWAY.CN's ROE of -0.27%. Regarding short-term risk, FH.NE is more volatile compared to GWAY.CN. This indicates higher risk in terms of short-term price fluctuations for FH.NE.Check GWAY.CN's competition here
Red Light Holland Corp. (CNQ: TRIP.CN)
FH.NE vs TRIP.CN Comparison August 2026
Filament Health Corp. (NEO: FH.NE) plays a significant role within the Healthcare sector. Its performance on the NEO reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FH.NE stands at 3.9M. In comparison, TRIP.CN has a market cap of 12.6M. Regarding current trading prices, FH.NE is priced at CA$0.01 on the NEO, while TRIP.CN trades at CA$0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FH.NE currently has a P/E ratio of -0.50, whereas TRIP.CN's P/E ratio is -2.80. In terms of profitability, FH.NE's ROE is -1.38%, compared to TRIP.CN's ROE of -0.41%. Regarding short-term risk, FH.NE is more volatile compared to TRIP.CN. This indicates higher risk in terms of short-term price fluctuations for FH.NE.Check TRIP.CN's competition here
Orion Nutraceuticals Inc. (CNQ: ORI.CN)
FH.NE vs ORI.CN Comparison August 2026
Filament Health Corp. (NEO: FH.NE) plays a significant role within the Healthcare sector. Its performance on the NEO reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FH.NE stands at 3.9M. In comparison, ORI.CN has a market cap of 11.7M. Regarding current trading prices, FH.NE is priced at CA$0.01 on the NEO, while ORI.CN trades at CA$0.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FH.NE currently has a P/E ratio of -0.50, whereas ORI.CN's P/E ratio is -2.11. In terms of profitability, FH.NE's ROE is -1.38%, compared to ORI.CN's ROE of +0.07%. Regarding short-term risk, FH.NE is more volatile compared to ORI.CN. This indicates higher risk in terms of short-term price fluctuations for FH.NE.Check ORI.CN's competition here
Revive Therapeutics Ltd. (CNQ: RVV.CN)
FH.NE vs RVV.CN Comparison August 2026
Filament Health Corp. (NEO: FH.NE) plays a significant role within the Healthcare sector. Its performance on the NEO reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FH.NE stands at 3.9M. In comparison, RVV.CN has a market cap of 10.9M. Regarding current trading prices, FH.NE is priced at CA$0.01 on the NEO, while RVV.CN trades at CA$0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FH.NE currently has a P/E ratio of -0.50, whereas RVV.CN's P/E ratio is -17.86. In terms of profitability, FH.NE's ROE is -1.38%, compared to RVV.CN's ROE of +2.89%. Regarding short-term risk, FH.NE is more volatile compared to RVV.CN. This indicates higher risk in terms of short-term price fluctuations for FH.NE.Check RVV.CN's competition here
Avant Brands Inc. (TSX: AVNT.TO)
FH.NE vs AVNT.TO Comparison August 2026
Filament Health Corp. (NEO: FH.NE) plays a significant role within the Healthcare sector. Its performance on the NEO reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FH.NE stands at 3.9M. In comparison, AVNT.TO has a market cap of 10.1M. Regarding current trading prices, FH.NE is priced at CA$0.01 on the NEO, while AVNT.TO trades at CA$0.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FH.NE currently has a P/E ratio of -0.50, whereas AVNT.TO's P/E ratio is -0.71. In terms of profitability, FH.NE's ROE is -1.38%, compared to AVNT.TO's ROE of -0.50%. Regarding short-term risk, FH.NE is more volatile compared to AVNT.TO. This indicates higher risk in terms of short-term price fluctuations for FH.NE.Check AVNT.TO's competition here
CanaFarma Hemp Products Corp. (CNQ: CNFA.CN)
FH.NE vs CNFA.CN Comparison August 2026
Filament Health Corp. (NEO: FH.NE) plays a significant role within the Healthcare sector. Its performance on the NEO reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FH.NE stands at 3.9M. In comparison, CNFA.CN has a market cap of 9.8M. Regarding current trading prices, FH.NE is priced at CA$0.01 on the NEO, while CNFA.CN trades at CA$0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FH.NE currently has a P/E ratio of -0.50, whereas CNFA.CN's P/E ratio is -0.83. In terms of profitability, FH.NE's ROE is -1.38%, compared to CNFA.CN's ROE of -7.84%. Regarding short-term risk, FH.NE is more volatile compared to CNFA.CN. This indicates higher risk in terms of short-term price fluctuations for FH.NE.Check CNFA.CN's competition here
VIVO Cannabis Inc. (TSX: VIVO.TO)
FH.NE vs VIVO.TO Comparison August 2026
Filament Health Corp. (NEO: FH.NE) plays a significant role within the Healthcare sector. Its performance on the NEO reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FH.NE stands at 3.9M. In comparison, VIVO.TO has a market cap of 9.3M. Regarding current trading prices, FH.NE is priced at CA$0.01 on the NEO, while VIVO.TO trades at CA$0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FH.NE currently has a P/E ratio of -0.50, whereas VIVO.TO's P/E ratio is -0.16. In terms of profitability, FH.NE's ROE is -1.38%, compared to VIVO.TO's ROE of -0.78%. Regarding short-term risk, FH.NE is more volatile compared to VIVO.TO. This indicates higher risk in terms of short-term price fluctuations for FH.NE.Check VIVO.TO's competition here
CLS Holdings USA, Inc. (CNQ: CLSH.CN)
FH.NE vs CLSH.CN Comparison August 2026
Filament Health Corp. (NEO: FH.NE) plays a significant role within the Healthcare sector. Its performance on the NEO reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FH.NE stands at 3.9M. In comparison, CLSH.CN has a market cap of 8.1M. Regarding current trading prices, FH.NE is priced at CA$0.01 on the NEO, while CLSH.CN trades at CA$0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FH.NE currently has a P/E ratio of -0.50, whereas CLSH.CN's P/E ratio is 3.50. In terms of profitability, FH.NE's ROE is -1.38%, compared to CLSH.CN's ROE of +0.37%. Regarding short-term risk, FH.NE is more volatile compared to CLSH.CN. This indicates higher risk in terms of short-term price fluctuations for FH.NE.Check CLSH.CN's competition here
Aleafia Health Inc. (TSX: AH.TO)
FH.NE vs AH.TO Comparison August 2026
Filament Health Corp. (NEO: FH.NE) plays a significant role within the Healthcare sector. Its performance on the NEO reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FH.NE stands at 3.9M. In comparison, AH.TO has a market cap of 8.1M. Regarding current trading prices, FH.NE is priced at CA$0.01 on the NEO, while AH.TO trades at CA$0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FH.NE currently has a P/E ratio of -0.50, whereas AH.TO's P/E ratio is -0.22. In terms of profitability, FH.NE's ROE is -1.38%, compared to AH.TO's ROE of -0.58%. Regarding short-term risk, FH.NE is more volatile compared to AH.TO. This indicates higher risk in terms of short-term price fluctuations for FH.NE.Check AH.TO's competition here
Australis Capital Inc. (CNQ: AUSA.CN)
FH.NE vs AUSA.CN Comparison August 2026
Filament Health Corp. (NEO: FH.NE) plays a significant role within the Healthcare sector. Its performance on the NEO reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FH.NE stands at 3.9M. In comparison, AUSA.CN has a market cap of 7.8M. Regarding current trading prices, FH.NE is priced at CA$0.01 on the NEO, while AUSA.CN trades at CA$0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FH.NE currently has a P/E ratio of -0.50, whereas AUSA.CN's P/E ratio is -0.32. In terms of profitability, FH.NE's ROE is -1.38%, compared to AUSA.CN's ROE of -1.15%. Regarding short-term risk, FH.NE is more volatile compared to AUSA.CN. This indicates higher risk in terms of short-term price fluctuations for FH.NE.Check AUSA.CN's competition here
StateHouse Holdings Inc. (CNQ: STHZ.CN)
FH.NE vs STHZ.CN Comparison August 2026
Filament Health Corp. (NEO: FH.NE) plays a significant role within the Healthcare sector. Its performance on the NEO reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FH.NE stands at 3.9M. In comparison, STHZ.CN has a market cap of 7.7M. Regarding current trading prices, FH.NE is priced at CA$0.01 on the NEO, while STHZ.CN trades at CA$0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FH.NE currently has a P/E ratio of -0.50, whereas STHZ.CN's P/E ratio is -0.10. In terms of profitability, FH.NE's ROE is -1.38%, compared to STHZ.CN's ROE of +0.36%. Regarding short-term risk, FH.NE is more volatile compared to STHZ.CN. This indicates higher risk in terms of short-term price fluctuations for FH.NE.Check STHZ.CN's competition here
Christina Lake Cannabis Corp. (CNQ: CLC.CN)
FH.NE vs CLC.CN Comparison August 2026
Filament Health Corp. (NEO: FH.NE) plays a significant role within the Healthcare sector. Its performance on the NEO reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FH.NE stands at 3.9M. In comparison, CLC.CN has a market cap of 7.4M. Regarding current trading prices, FH.NE is priced at CA$0.01 on the NEO, while CLC.CN trades at CA$0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FH.NE currently has a P/E ratio of -0.50, whereas CLC.CN's P/E ratio is 12.50. In terms of profitability, FH.NE's ROE is -1.38%, compared to CLC.CN's ROE of -0.31%. Regarding short-term risk, FH.NE is more volatile compared to CLC.CN. This indicates higher risk in terms of short-term price fluctuations for FH.NE.Check CLC.CN's competition here
Blueberries Medical Corp. (CNQ: BBM.CN)
FH.NE vs BBM.CN Comparison August 2026
Filament Health Corp. (NEO: FH.NE) plays a significant role within the Healthcare sector. Its performance on the NEO reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FH.NE stands at 3.9M. In comparison, BBM.CN has a market cap of 7.4M. Regarding current trading prices, FH.NE is priced at CA$0.01 on the NEO, while BBM.CN trades at CA$0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FH.NE currently has a P/E ratio of -0.50, whereas BBM.CN's P/E ratio is -4.95. In terms of profitability, FH.NE's ROE is -1.38%, compared to BBM.CN's ROE of -1.92%. Regarding short-term risk, FH.NE is more volatile compared to BBM.CN. This indicates higher risk in terms of short-term price fluctuations for FH.NE.Check BBM.CN's competition here
Sproutly Canada Inc. (CNQ: SPR.CN)
FH.NE vs SPR.CN Comparison August 2026
Filament Health Corp. (NEO: FH.NE) plays a significant role within the Healthcare sector. Its performance on the NEO reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FH.NE stands at 3.9M. In comparison, SPR.CN has a market cap of 7.3M. Regarding current trading prices, FH.NE is priced at CA$0.01 on the NEO, while SPR.CN trades at CA$0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FH.NE currently has a P/E ratio of -0.50, whereas SPR.CN's P/E ratio is -0.49. In terms of profitability, FH.NE's ROE is -1.38%, compared to SPR.CN's ROE of +18.75%. Regarding short-term risk, FH.NE is more volatile compared to SPR.CN. This indicates higher risk in terms of short-term price fluctuations for FH.NE.Check SPR.CN's competition here
Mojave Brands Inc. (CNQ: MOJO.CN)
FH.NE vs MOJO.CN Comparison August 2026
Filament Health Corp. (NEO: FH.NE) plays a significant role within the Healthcare sector. Its performance on the NEO reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FH.NE stands at 3.9M. In comparison, MOJO.CN has a market cap of 7M. Regarding current trading prices, FH.NE is priced at CA$0.01 on the NEO, while MOJO.CN trades at CA$0.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FH.NE currently has a P/E ratio of -0.50, whereas MOJO.CN's P/E ratio is -8.45. In terms of profitability, FH.NE's ROE is -1.38%, compared to MOJO.CN's ROE of -0.77%. Regarding short-term risk, FH.NE is more volatile compared to MOJO.CN. This indicates higher risk in terms of short-term price fluctuations for FH.NE.Check MOJO.CN's competition here
Nextleaf Solutions Ltd. (CNQ: OILS.CN)
FH.NE vs OILS.CN Comparison August 2026
Filament Health Corp. (NEO: FH.NE) plays a significant role within the Healthcare sector. Its performance on the NEO reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FH.NE stands at 3.9M. In comparison, OILS.CN has a market cap of 6.8M. Regarding current trading prices, FH.NE is priced at CA$0.01 on the NEO, while OILS.CN trades at CA$0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FH.NE currently has a P/E ratio of -0.50, whereas OILS.CN's P/E ratio is -4.72. In terms of profitability, FH.NE's ROE is -1.38%, compared to OILS.CN's ROE of -0.30%. Regarding short-term risk, FH.NE is more volatile compared to OILS.CN. This indicates higher risk in terms of short-term price fluctuations for FH.NE.Check OILS.CN's competition here
Sweet Earth Holdings Corporation (CNQ: SE.CN)
FH.NE vs SE.CN Comparison August 2026
Filament Health Corp. (NEO: FH.NE) plays a significant role within the Healthcare sector. Its performance on the NEO reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FH.NE stands at 3.9M. In comparison, SE.CN has a market cap of 6.6M. Regarding current trading prices, FH.NE is priced at CA$0.01 on the NEO, while SE.CN trades at CA$0.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FH.NE currently has a P/E ratio of -0.50, whereas SE.CN's P/E ratio is -0.60. In terms of profitability, FH.NE's ROE is -1.38%, compared to SE.CN's ROE of -15.22%. Regarding short-term risk, FH.NE is more volatile compared to SE.CN. This indicates higher risk in terms of short-term price fluctuations for FH.NE.Check SE.CN's competition here
Sunniva Inc. (CNQ: SNN.CN)
FH.NE vs SNN.CN Comparison August 2026
Filament Health Corp. (NEO: FH.NE) plays a significant role within the Healthcare sector. Its performance on the NEO reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FH.NE stands at 3.9M. In comparison, SNN.CN has a market cap of 6.1M. Regarding current trading prices, FH.NE is priced at CA$0.01 on the NEO, while SNN.CN trades at CA$0.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FH.NE currently has a P/E ratio of -0.50, whereas SNN.CN's P/E ratio is -0.13. In terms of profitability, FH.NE's ROE is -1.38%, compared to SNN.CN's ROE of -0.49%. Regarding short-term risk, FH.NE is more volatile compared to SNN.CN. This indicates higher risk in terms of short-term price fluctuations for FH.NE.Check SNN.CN's competition here
CordovaCann Corp. (CNQ: CDVA.CN)
FH.NE vs CDVA.CN Comparison August 2026
Filament Health Corp. (NEO: FH.NE) plays a significant role within the Healthcare sector. Its performance on the NEO reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FH.NE stands at 3.9M. In comparison, CDVA.CN has a market cap of 5.5M. Regarding current trading prices, FH.NE is priced at CA$0.01 on the NEO, while CDVA.CN trades at CA$0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FH.NE currently has a P/E ratio of -0.50, whereas CDVA.CN's P/E ratio is -1.09. In terms of profitability, FH.NE's ROE is -1.38%, compared to CDVA.CN's ROE of +0.44%. Regarding short-term risk, FH.NE is more volatile compared to CDVA.CN. This indicates higher risk in terms of short-term price fluctuations for FH.NE.Check CDVA.CN's competition here
1933 Industries Inc. (CNQ: TGIF.CN)
FH.NE vs TGIF.CN Comparison August 2026
Filament Health Corp. (NEO: FH.NE) plays a significant role within the Healthcare sector. Its performance on the NEO reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FH.NE stands at 3.9M. In comparison, TGIF.CN has a market cap of 5.2M. Regarding current trading prices, FH.NE is priced at CA$0.01 on the NEO, while TGIF.CN trades at CA$0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FH.NE currently has a P/E ratio of -0.50, whereas TGIF.CN's P/E ratio is 4.27. In terms of profitability, FH.NE's ROE is -1.38%, compared to TGIF.CN's ROE of -0.12%. Regarding short-term risk, FH.NE is more volatile compared to TGIF.CN. This indicates higher risk in terms of short-term price fluctuations for FH.NE.Check TGIF.CN's competition here
Willow Biosciences Inc. (TSX: WLLW.TO)
FH.NE vs WLLW.TO Comparison August 2026
Filament Health Corp. (NEO: FH.NE) plays a significant role within the Healthcare sector. Its performance on the NEO reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FH.NE stands at 3.9M. In comparison, WLLW.TO has a market cap of 5.2M. Regarding current trading prices, FH.NE is priced at CA$0.01 on the NEO, while WLLW.TO trades at CA$0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FH.NE currently has a P/E ratio of -0.50, whereas WLLW.TO's P/E ratio is -0.22. In terms of profitability, FH.NE's ROE is -1.38%, compared to WLLW.TO's ROE of +0.00%. Regarding short-term risk, FH.NE is more volatile compared to WLLW.TO. This indicates higher risk in terms of short-term price fluctuations for FH.NE.Check WLLW.TO's competition here
The BC Bud Corporation (CNQ: BCBC.CN)
FH.NE vs BCBC.CN Comparison August 2026
Filament Health Corp. (NEO: FH.NE) plays a significant role within the Healthcare sector. Its performance on the NEO reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FH.NE stands at 3.9M. In comparison, BCBC.CN has a market cap of 5M. Regarding current trading prices, FH.NE is priced at CA$0.01 on the NEO, while BCBC.CN trades at CA$0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FH.NE currently has a P/E ratio of -0.50, whereas BCBC.CN's P/E ratio is -2.00. In terms of profitability, FH.NE's ROE is -1.38%, compared to BCBC.CN's ROE of -1.93%. Regarding short-term risk, FH.NE is more volatile compared to BCBC.CN. This indicates higher risk in terms of short-term price fluctuations for FH.NE.Check BCBC.CN's competition here
Heritage Cannabis Holdings Corp. (CNQ: CANN.CN)
FH.NE vs CANN.CN Comparison August 2026
Filament Health Corp. (NEO: FH.NE) plays a significant role within the Healthcare sector. Its performance on the NEO reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FH.NE stands at 3.9M. In comparison, CANN.CN has a market cap of 4.7M. Regarding current trading prices, FH.NE is priced at CA$0.01 on the NEO, while CANN.CN trades at CA$0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FH.NE currently has a P/E ratio of -0.50, whereas CANN.CN's P/E ratio is -0.22. In terms of profitability, FH.NE's ROE is -1.38%, compared to CANN.CN's ROE of -0.66%. Regarding short-term risk, FH.NE is more volatile compared to CANN.CN. This indicates higher risk in terms of short-term price fluctuations for FH.NE.Check CANN.CN's competition here
Bhang Inc. (CNQ: BHNG.CN)
FH.NE vs BHNG.CN Comparison August 2026
Filament Health Corp. (NEO: FH.NE) plays a significant role within the Healthcare sector. Its performance on the NEO reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FH.NE stands at 3.9M. In comparison, BHNG.CN has a market cap of 4.7M. Regarding current trading prices, FH.NE is priced at CA$0.01 on the NEO, while BHNG.CN trades at CA$0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FH.NE currently has a P/E ratio of -0.50, whereas BHNG.CN's P/E ratio is -0.94. In terms of profitability, FH.NE's ROE is -1.38%, compared to BHNG.CN's ROE of +4.00%. Regarding short-term risk, FH.NE is more volatile compared to BHNG.CN. This indicates higher risk in terms of short-term price fluctuations for FH.NE.Check BHNG.CN's competition here
4Front Ventures Corp. (CNQ: FFNT.CN)
FH.NE vs FFNT.CN Comparison August 2026
Filament Health Corp. (NEO: FH.NE) plays a significant role within the Healthcare sector. Its performance on the NEO reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FH.NE stands at 3.9M. In comparison, FFNT.CN has a market cap of 4.6M. Regarding current trading prices, FH.NE is priced at CA$0.01 on the NEO, while FFNT.CN trades at CA$0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FH.NE currently has a P/E ratio of -0.50, whereas FFNT.CN's P/E ratio is -0.03. In terms of profitability, FH.NE's ROE is -1.38%, compared to FFNT.CN's ROE of +7.89%. Regarding short-term risk, FH.NE is more volatile compared to FFNT.CN. This indicates higher risk in terms of short-term price fluctuations for FH.NE.Check FFNT.CN's competition here
Luff Enterprises Ltd. (CNQ: LUFF.CN)
FH.NE vs LUFF.CN Comparison August 2026
Filament Health Corp. (NEO: FH.NE) plays a significant role within the Healthcare sector. Its performance on the NEO reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FH.NE stands at 3.9M. In comparison, LUFF.CN has a market cap of 4M. Regarding current trading prices, FH.NE is priced at CA$0.01 on the NEO, while LUFF.CN trades at CA$0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FH.NE currently has a P/E ratio of -0.50, whereas LUFF.CN's P/E ratio is -0.56. In terms of profitability, FH.NE's ROE is -1.38%, compared to LUFF.CN's ROE of -0.32%. Regarding short-term risk, FH.NE is not fully comparable compared to LUFF.CN. This indicates unavailable risk data in terms of short-term price fluctuations for FH.NE.Check LUFF.CN's competition here
Body and Mind Inc. (CNQ: BAMM.CN)
FH.NE vs BAMM.CN Comparison August 2026
Filament Health Corp. (NEO: FH.NE) plays a significant role within the Healthcare sector. Its performance on the NEO reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FH.NE stands at 3.9M. In comparison, BAMM.CN has a market cap of 3.7M. Regarding current trading prices, FH.NE is priced at CA$0.01 on the NEO, while BAMM.CN trades at CA$0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FH.NE currently has a P/E ratio of -0.50, whereas BAMM.CN's P/E ratio is -0.01. In terms of profitability, FH.NE's ROE is -1.38%, compared to BAMM.CN's ROE of +65.27%. Regarding short-term risk, FH.NE is more volatile compared to BAMM.CN. This indicates higher risk in terms of short-term price fluctuations for FH.NE.Check BAMM.CN's competition here
TILT Holdings Inc. (NEO: TILT.NE)
FH.NE vs TILT.NE Comparison August 2026
Filament Health Corp. (NEO: FH.NE) plays a significant role within the Healthcare sector. Its performance on the NEO reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FH.NE stands at 3.9M. In comparison, TILT.NE has a market cap of 3.5M. Regarding current trading prices, FH.NE is priced at CA$0.01 on the NEO, while TILT.NE trades at CA$0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FH.NE currently has a P/E ratio of -0.50, whereas TILT.NE's P/E ratio is -0.03. In terms of profitability, FH.NE's ROE is -1.38%, compared to TILT.NE's ROE of +0.45%. Regarding short-term risk, FH.NE is more volatile compared to TILT.NE. This indicates higher risk in terms of short-term price fluctuations for FH.NE.Check TILT.NE's competition here
Refined Metals Corp. (CNQ: RMC.CN)
FH.NE vs RMC.CN Comparison August 2026
Filament Health Corp. (NEO: FH.NE) plays a significant role within the Healthcare sector. Its performance on the NEO reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FH.NE stands at 3.9M. In comparison, RMC.CN has a market cap of 3.4M. Regarding current trading prices, FH.NE is priced at CA$0.01 on the NEO, while RMC.CN trades at CA$0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FH.NE currently has a P/E ratio of -0.50, whereas RMC.CN's P/E ratio is -4.00. In terms of profitability, FH.NE's ROE is -1.38%, compared to RMC.CN's ROE of +1.25%. Regarding short-term risk, FH.NE is more volatile compared to RMC.CN. This indicates higher risk in terms of short-term price fluctuations for FH.NE.Check RMC.CN's competition here
THC Biomed Intl Ltd. (CNQ: THC.CN)
FH.NE vs THC.CN Comparison August 2026
Filament Health Corp. (NEO: FH.NE) plays a significant role within the Healthcare sector. Its performance on the NEO reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FH.NE stands at 3.9M. In comparison, THC.CN has a market cap of 3.3M. Regarding current trading prices, FH.NE is priced at CA$0.01 on the NEO, while THC.CN trades at CA$0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FH.NE currently has a P/E ratio of -0.50, whereas THC.CN's P/E ratio is -0.89. In terms of profitability, FH.NE's ROE is -1.38%, compared to THC.CN's ROE of -0.37%. Regarding short-term risk, FH.NE is more volatile compared to THC.CN. This indicates higher risk in terms of short-term price fluctuations for FH.NE.Check THC.CN's competition here
North Bud Farms Inc. (CNQ: NBUD.CN)
FH.NE vs NBUD.CN Comparison August 2026
Filament Health Corp. (NEO: FH.NE) plays a significant role within the Healthcare sector. Its performance on the NEO reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FH.NE stands at 3.9M. In comparison, NBUD.CN has a market cap of 3.2M. Regarding current trading prices, FH.NE is priced at CA$0.01 on the NEO, while NBUD.CN trades at CA$0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FH.NE currently has a P/E ratio of -0.50, whereas NBUD.CN's P/E ratio is -1.25. In terms of profitability, FH.NE's ROE is -1.38%, compared to NBUD.CN's ROE of -0.27%. Regarding short-term risk, FH.NE is more volatile compared to NBUD.CN. This indicates higher risk in terms of short-term price fluctuations for FH.NE.Check NBUD.CN's competition here
ManifestSeven Holdings Corporation (CNQ: MSVN.CN)
FH.NE vs MSVN.CN Comparison August 2026
Filament Health Corp. (NEO: FH.NE) plays a significant role within the Healthcare sector. Its performance on the NEO reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FH.NE stands at 3.9M. In comparison, MSVN.CN has a market cap of 2.9M. Regarding current trading prices, FH.NE is priced at CA$0.01 on the NEO, while MSVN.CN trades at CA$0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FH.NE currently has a P/E ratio of -0.50, whereas MSVN.CN's P/E ratio is -0.06. In terms of profitability, FH.NE's ROE is -1.38%, compared to MSVN.CN's ROE of +19.42%. Regarding short-term risk, FH.NE is more volatile compared to MSVN.CN. This indicates higher risk in terms of short-term price fluctuations for FH.NE.Check MSVN.CN's competition here
AREV Life Sciences Global Corp. (CNQ: AREV.CN)
FH.NE vs AREV.CN Comparison August 2026
Filament Health Corp. (NEO: FH.NE) plays a significant role within the Healthcare sector. Its performance on the NEO reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FH.NE stands at 3.9M. In comparison, AREV.CN has a market cap of 2.8M. Regarding current trading prices, FH.NE is priced at CA$0.01 on the NEO, while AREV.CN trades at CA$0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FH.NE currently has a P/E ratio of -0.50, whereas AREV.CN's P/E ratio is -98.90. In terms of profitability, FH.NE's ROE is -1.38%, compared to AREV.CN's ROE of +2.76%. Regarding short-term risk, FH.NE is more volatile compared to AREV.CN. This indicates higher risk in terms of short-term price fluctuations for FH.NE.Check AREV.CN's competition here
Acerus Pharmaceuticals Corporation (TSX: ASP.TO)
FH.NE vs ASP.TO Comparison August 2026
Filament Health Corp. (NEO: FH.NE) plays a significant role within the Healthcare sector. Its performance on the NEO reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FH.NE stands at 3.9M. In comparison, ASP.TO has a market cap of 2.8M. Regarding current trading prices, FH.NE is priced at CA$0.01 on the NEO, while ASP.TO trades at CA$0.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FH.NE currently has a P/E ratio of -0.50, whereas ASP.TO's P/E ratio is -0.08. In terms of profitability, FH.NE's ROE is -1.38%, compared to ASP.TO's ROE of +3.10%. Regarding short-term risk, FH.NE is more volatile compared to ASP.TO. This indicates higher risk in terms of short-term price fluctuations for FH.NE.Check ASP.TO's competition here
Craftport Cannabis Corp. (CNQ: CFT.CN)
FH.NE vs CFT.CN Comparison August 2026
Filament Health Corp. (NEO: FH.NE) plays a significant role within the Healthcare sector. Its performance on the NEO reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FH.NE stands at 3.9M. In comparison, CFT.CN has a market cap of 2.7M. Regarding current trading prices, FH.NE is priced at CA$0.01 on the NEO, while CFT.CN trades at CA$0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FH.NE currently has a P/E ratio of -0.50, whereas CFT.CN's P/E ratio is -0.13. In terms of profitability, FH.NE's ROE is -1.38%, compared to CFT.CN's ROE of -2.12%. Regarding short-term risk, FH.NE is more volatile compared to CFT.CN. This indicates higher risk in terms of short-term price fluctuations for FH.NE.Check CFT.CN's competition here
Isracann Biosciences Inc. (CNQ: IPOT.CN)
FH.NE vs IPOT.CN Comparison August 2026
Filament Health Corp. (NEO: FH.NE) plays a significant role within the Healthcare sector. Its performance on the NEO reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FH.NE stands at 3.9M. In comparison, IPOT.CN has a market cap of 2.6M. Regarding current trading prices, FH.NE is priced at CA$0.01 on the NEO, while IPOT.CN trades at CA$0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FH.NE currently has a P/E ratio of -0.50, whereas IPOT.CN's P/E ratio is -3.41. In terms of profitability, FH.NE's ROE is -1.38%, compared to IPOT.CN's ROE of -2.22%. Regarding short-term risk, FH.NE is more volatile compared to IPOT.CN. This indicates higher risk in terms of short-term price fluctuations for FH.NE.Check IPOT.CN's competition here
Aion Therapeutic Inc. (CNQ: AION.CN)
FH.NE vs AION.CN Comparison August 2026
Filament Health Corp. (NEO: FH.NE) plays a significant role within the Healthcare sector. Its performance on the NEO reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FH.NE stands at 3.9M. In comparison, AION.CN has a market cap of 2.5M. Regarding current trading prices, FH.NE is priced at CA$0.01 on the NEO, while AION.CN trades at CA$0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FH.NE currently has a P/E ratio of -0.50, whereas AION.CN's P/E ratio is -1.09. In terms of profitability, FH.NE's ROE is -1.38%, compared to AION.CN's ROE of +1.91%. Regarding short-term risk, FH.NE is more volatile compared to AION.CN. This indicates higher risk in terms of short-term price fluctuations for FH.NE.Check AION.CN's competition here
Flower One Holdings Inc. (CNQ: FONE.CN)
FH.NE vs FONE.CN Comparison August 2026
Filament Health Corp. (NEO: FH.NE) plays a significant role within the Healthcare sector. Its performance on the NEO reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FH.NE stands at 3.9M. In comparison, FONE.CN has a market cap of 2.4M. Regarding current trading prices, FH.NE is priced at CA$0.01 on the NEO, while FONE.CN trades at CA$0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FH.NE currently has a P/E ratio of -0.50, whereas FONE.CN's P/E ratio is -0.10. In terms of profitability, FH.NE's ROE is -1.38%, compared to FONE.CN's ROE of +8.32%. Regarding short-term risk, FH.NE is more volatile compared to FONE.CN. This indicates higher risk in terms of short-term price fluctuations for FH.NE.Check FONE.CN's competition here
Choom Holdings Inc. (CNQ: CHOO.CN)
FH.NE vs CHOO.CN Comparison August 2026
Filament Health Corp. (NEO: FH.NE) plays a significant role within the Healthcare sector. Its performance on the NEO reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FH.NE stands at 3.9M. In comparison, CHOO.CN has a market cap of 2.3M. Regarding current trading prices, FH.NE is priced at CA$0.01 on the NEO, while CHOO.CN trades at CA$0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FH.NE currently has a P/E ratio of -0.50, whereas CHOO.CN's P/E ratio is -0.10. In terms of profitability, FH.NE's ROE is -1.38%, compared to CHOO.CN's ROE of +4.09%. Regarding short-term risk, FH.NE is more volatile compared to CHOO.CN. This indicates higher risk in terms of short-term price fluctuations for FH.NE.Check CHOO.CN's competition here
West Island Brands Inc. (CNQ: WIB.CN)
FH.NE vs WIB.CN Comparison August 2026
Filament Health Corp. (NEO: FH.NE) plays a significant role within the Healthcare sector. Its performance on the NEO reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FH.NE stands at 3.9M. In comparison, WIB.CN has a market cap of 2.2M. Regarding current trading prices, FH.NE is priced at CA$0.01 on the NEO, while WIB.CN trades at CA$0.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FH.NE currently has a P/E ratio of -0.50, whereas WIB.CN's P/E ratio is -0.39. In terms of profitability, FH.NE's ROE is -1.38%, compared to WIB.CN's ROE of -1.00%. Regarding short-term risk, FH.NE is more volatile compared to WIB.CN. This indicates higher risk in terms of short-term price fluctuations for FH.NE.Check WIB.CN's competition here
CBD Global Sciences Inc. (CNQ: CBDN.CN)
FH.NE vs CBDN.CN Comparison August 2026
Filament Health Corp. (NEO: FH.NE) plays a significant role within the Healthcare sector. Its performance on the NEO reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FH.NE stands at 3.9M. In comparison, CBDN.CN has a market cap of 2.2M. Regarding current trading prices, FH.NE is priced at CA$0.01 on the NEO, while CBDN.CN trades at CA$0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FH.NE currently has a P/E ratio of -0.50, whereas CBDN.CN's P/E ratio is -0.25. In terms of profitability, FH.NE's ROE is -1.38%, compared to CBDN.CN's ROE of +1.16%. Regarding short-term risk, FH.NE is more volatile compared to CBDN.CN. This indicates higher risk in terms of short-term price fluctuations for FH.NE.Check CBDN.CN's competition here